Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010 PLLVF, OXIS, PKOL, ORNID, SIDNF Have Been Added To Naked Short Lists Today
October 4, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. Palladon Ventures (OTC: PLLVF), Oxis International (OTCBB: OXIS), PowerShares Global Coal (NASDAQ: PKOL), Oragenics (OTCBB: ORNID) and Sidon International Resources (OTC: SIDNF). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Palladon Ventures Ltd. (OTC: PLLVF), a junior resource company, engages in the acquisition, exploration, and development of mineral resource properties worldwide. It primarily focuses on developing the Comstock/Mountain Lion iron mine in Iron County, Utah. The company also holds gold exploration projects in Nevada, Utah, and Argentina. Palladon Ventures Ltd. was incorporated in 1980 and is headquartered in Salt Lake City, Utah. There is a failure to deliver in shares of PLLVF.
OXIS International, Inc. (OTCBB: OXIS) engages in the research, development, and marketing of nutraceutical and cosmeceutical products in the field of oxidative stress reduction and inflammation. The company primarily focuses on developing a line of dietary supplements containing L-Ergothioneine (ERGO). ERGO is naturally occurring, water soluble, and amino acid antioxidant produced by microbes in the soil and found in various species of mushrooms and grapes, meats, and dairy products. It offers Ergo-Plex, a dietary supplement for the maintenance of joint health. The company also holds patents and patent applications for the protection of ERGO on mitochondria, the ERGO manufacturing process, and the neuroprotectant methods and compositions of ERGO. OXIS International, Inc. was founded in 1965 and is based in Beverly Hills, California. There is a failure to deliver in shares of OXIS.
PowerShares Global Coal (NASDAQ: PKOL). The investment seeks to replicate, net of expenses, the NASDAQ OMX Global Coal Index. The fund normally invests at least 90% of assets in the securities and ADRs and GDRs based on the securities that comprise the underlying index. It normally invests at least 80% of its total assets in securities of companies involved in the coal industry. The index is designed to measure the overall performance of globally traded securities of the largest and most liquid companies involved in the coal industry. The fund is nondiversified. There is a failure to deliver in shares of PKOL.
Oragenics, Inc. (OTCBB: ORNID), a biopharmaceutical company, engages in the discovery, development, and commercialization of various products and technologies associated with oral health, antibiotics, and other general health benefits in the United States. The company also has various products in discovery, preclinical, and clinical development concentrating in the therapeutic area of infectious diseases, in diagnostics, and in oral health. It operates in four divisions: Consumer Healthcare, Biomarker Discovery, Antibiotics, and Biologics. The Consumer Healthcare division develops oral probiotics based on the ProBiora3 technology that employs three natural strains of beneficial bacteria, which promote oral health; and weight loss products based on the LPT3-04, a weight loss agent (food/nutritional supplement). The Biomarker Discovery division offers Proteomic-based in-vivo induced antigen technology and Proteomic-based change mediated antigen technology platforms for the identification of genetic targets used in diagnostic tests, as well as in vaccines and therapeutics. The Antibiotics division is developing DPOLT or differentially protected orthogonal lantionine technology, a solid/liquid phase peptide synthesis platform technology that has various application for the manufacture of commercially important bioactive peptides, including lantibiotics; and MU 1140 an antibiotic with antimicrobial activity against drug resistant organisms, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, and Streptococcus pneumoniae. The Biologics division develops SMaRT Replacement Therapy, a topical treatment under Phase I clinical trial against dental caries. The company, formerly known as Oragen, Inc., was founded in 1996 and is based in Alachua, Florida. There is a failure to deliver in shares of ORNID.
Sidon International Resources Corporation (OTC: SIDNF) engages in the acquisition, exploration, and development of precious metal mineral properties in Canada and the United States. It focuses on the exploration of diamond, gold, copper, other base metals, coal, and potash properties in Saskatchewan, Alberta, British Columbia, Northwest Territories, and Nevada. The company was founded in 1987 and is headquartered in Everett, Washington. There is a failure to deliver in shares of SIDNF.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com